Lv4
500 积分 2023-03-30 加入
Changes in the incidence and overall survival of patients with myeloproliferative neoplasms between 2002 and 2016 in the United States
16天前
已完结
Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation
16天前
已完结
Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists
17天前
已完结
Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience
17天前
已完结
Selective histone deacetylase inhibitor after allo-HCT for T-cell acute lymphoblastic leukemia or T-cell lymphoma
18天前
已完结
The role of interferon‐gamma and its signaling pathway in pediatric hematological disorders
22天前
已完结
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
22天前
已完结
Second primary malignancy in myelofibrosis patients treated with ruxolitinib
23天前
已完结
Higher red blood cell distribution width predicts thrombosis risk in primary and secondary myelofibrosis
23天前
已完结
A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER database
25天前
已完结
皖公网安备34019202002308
